You'll see fewer patients getting prescriptions for the antidepressant Serzone

You'll see fewer patients getting prescriptions for the antidepressant Serzone...due to concerns about liver toxicity.

Bristol-Myers Squibb just pulled it off the market in Europe.

The FDA added a black box warning last year.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote